Matches in SemOpenAlex for { <https://semopenalex.org/work/W2371245771> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W2371245771 abstract "Objective:To investigate the efficacy and safety of Nateglinide combined with Insulin Glargine in the treatment of type 2 diabetes patients with secondary sulfonylureas failure.Methods:Type 2 diabetes patients with secondary sulfonylureas failure were divided into two groups.The trial group was treated by Nateglinide with Insulin Glargine Injection.The control group was shifted to sulphanylureas drugs plus Glargine.Both groups were under treatment for three months with determining the fasting blood glucose(FBG),2 hour postprandial blood(2 h PG),glycosylated hemoglobin(HbA 1c) and C-peptide before and after the treatment as well as adverse reactions.Results:After treatment,the levels of FBG,2 h PG,and HbA1c in trial and control group decreased significantly compared with those before treatment(P0.05 or P0.01),but there was no significant difference in the decrease of FBG and HbA1c,increase of C-peptide,30 min C-peptide,120 min C-peptide between the two groups(P0.05).The 2 h PG and C-peptide in trial and control group decreased and raised significantly seperately(P0.05).The peak of C-peptide of trial group occurred 1 hour after meal and was higher than that of control group(P0.05),the peak of C-peptide of control group occurred 3 hours after meal and was higher than that of trial group(P0.05).The main adverse reaction was hypoglycemia,showing significant difference between the two groups(P0.05).Conclusion:Nateglinide combined with Insulin Glargine can control the blood glucose effectively in type 2 diabetes patients of secondary sulphanyluteas drugs failure with low incidence of hypoglycemia and high safety accompanied." @default.
- W2371245771 created "2016-06-24" @default.
- W2371245771 creator A5088663125 @default.
- W2371245771 date "2010-01-01" @default.
- W2371245771 modified "2023-09-24" @default.
- W2371245771 title "Therapeutic effect and safety of Nateglinide combined with Insulin Glargine in the treatment of type 2 diabetes patients with secondary sulphanyluteas drugs failure" @default.
- W2371245771 hasPublicationYear "2010" @default.
- W2371245771 type Work @default.
- W2371245771 sameAs 2371245771 @default.
- W2371245771 citedByCount "0" @default.
- W2371245771 crossrefType "journal-article" @default.
- W2371245771 hasAuthorship W2371245771A5088663125 @default.
- W2371245771 hasConcept C126322002 @default.
- W2371245771 hasConcept C134018914 @default.
- W2371245771 hasConcept C197934379 @default.
- W2371245771 hasConcept C2777180221 @default.
- W2371245771 hasConcept C2778199505 @default.
- W2371245771 hasConcept C2778875212 @default.
- W2371245771 hasConcept C2778917026 @default.
- W2371245771 hasConcept C2779306644 @default.
- W2371245771 hasConcept C2779463123 @default.
- W2371245771 hasConcept C2779920387 @default.
- W2371245771 hasConcept C2780668416 @default.
- W2371245771 hasConcept C555293320 @default.
- W2371245771 hasConcept C71924100 @default.
- W2371245771 hasConcept C90924648 @default.
- W2371245771 hasConcept C98274493 @default.
- W2371245771 hasConceptScore W2371245771C126322002 @default.
- W2371245771 hasConceptScore W2371245771C134018914 @default.
- W2371245771 hasConceptScore W2371245771C197934379 @default.
- W2371245771 hasConceptScore W2371245771C2777180221 @default.
- W2371245771 hasConceptScore W2371245771C2778199505 @default.
- W2371245771 hasConceptScore W2371245771C2778875212 @default.
- W2371245771 hasConceptScore W2371245771C2778917026 @default.
- W2371245771 hasConceptScore W2371245771C2779306644 @default.
- W2371245771 hasConceptScore W2371245771C2779463123 @default.
- W2371245771 hasConceptScore W2371245771C2779920387 @default.
- W2371245771 hasConceptScore W2371245771C2780668416 @default.
- W2371245771 hasConceptScore W2371245771C555293320 @default.
- W2371245771 hasConceptScore W2371245771C71924100 @default.
- W2371245771 hasConceptScore W2371245771C90924648 @default.
- W2371245771 hasConceptScore W2371245771C98274493 @default.
- W2371245771 hasLocation W23712457711 @default.
- W2371245771 hasOpenAccess W2371245771 @default.
- W2371245771 hasPrimaryLocation W23712457711 @default.
- W2371245771 hasRelatedWork W2355215749 @default.
- W2371245771 hasRelatedWork W2356987888 @default.
- W2371245771 hasRelatedWork W2357309745 @default.
- W2371245771 hasRelatedWork W2361562542 @default.
- W2371245771 hasRelatedWork W2361891169 @default.
- W2371245771 hasRelatedWork W2363217059 @default.
- W2371245771 hasRelatedWork W2365587066 @default.
- W2371245771 hasRelatedWork W2372436093 @default.
- W2371245771 hasRelatedWork W2379501405 @default.
- W2371245771 hasRelatedWork W2379709202 @default.
- W2371245771 hasRelatedWork W2380586011 @default.
- W2371245771 hasRelatedWork W2380625208 @default.
- W2371245771 hasRelatedWork W2380630618 @default.
- W2371245771 hasRelatedWork W2382782678 @default.
- W2371245771 hasRelatedWork W2383431167 @default.
- W2371245771 hasRelatedWork W2387047087 @default.
- W2371245771 hasRelatedWork W2392272057 @default.
- W2371245771 hasRelatedWork W3028864425 @default.
- W2371245771 hasRelatedWork W3029705737 @default.
- W2371245771 hasRelatedWork W3031382843 @default.
- W2371245771 isParatext "false" @default.
- W2371245771 isRetracted "false" @default.
- W2371245771 magId "2371245771" @default.
- W2371245771 workType "article" @default.